Status:
COMPLETED
Follow-up Using Patient-Reported Outcome (PRO) Measures in Patients With Chronic Kidney Disease
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Regional Hospital West Jutland
Aarhus University Hospital
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized controlled trial (RCT) will evaluate if PRO-based follow-up is at least as effective as usual outpatient follow-up in managing decline in renal function and maintaining patients' quali...
Detailed Description
This randomized controlled trial investigates the use of Patient-reported Outcome (PRO) follow-up among patients with chronic kidney disease. Usual outpatient follow-up visits will be replaced with di...
Eligibility Criteria
Inclusion
- Referred to the renal care services at Aarhus University Hospital or Regional Hospital Central Jutland, Viborg
- Estimated Glomerular Filtration Rate (eGFR) between 10-39 mL/min 1.73m2.
- Aged ≥18 years old
- Ability to provide fully informed written consent for participation in the study
Exclusion
- Patients unwilling to participate in PRO-based follow-up
- Patients who, in the opinion of the consenting professional, cannot speak, read or write Danish sufficiently well to complete the PRO questionnaire unaided
- Patients with hearing disabilities
- Patients with an eGFR \> 39mL/min 1.73m2 at their first visit at the hospital
- Patients who have received (or have a scheduled date to receive) a kidney transplant
- A terminal illness that, in the opinion of the consultant assessing eligibility, is likely to lead to the death of the patient within 6 months of starting participation in the study
- Patients receiving chemotherapy, with end stage Chronic Obstructive Lung disease, or with heart failure with Ejection Fraction (EF)\< 15 %.
- A projected risk of progression to end-stage renal failure within 6 months, determined from albumin/creatinine ratio
Key Trial Info
Start Date :
December 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2023
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT03847766
Start Date
December 3 2018
End Date
December 15 2023
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Birgith Engelst Grove
Herning, Denmark, 7400